CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium™ in Patients With Non-Invasive Urothelial Carcinoma in Situ (CIS) Previously Treated With Bacille Calmette-Guérin (BCG)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00462488
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:42.754823+00:00
Published At: 2020-05-12T00:00:00+00:00
Record Updated At: 2020-05-12
Results Posted At: 2020-05-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urinary Bladder Cancer", "Bladder Cancer", "Bladder Neoplasms", "Bladder Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-05-12"
protocolSection.identificationModule.nctId: "NCT00462488"
protocolSection.identificationModule.officialTitle: "Phase II Study to Evaluate the Efficacy and Tolerability of Intravesical Vicinium\u2122 in Patients With Non-Invasive Urothelial Carcinoma in Situ (CIS) Previously Treated With Bacille Calmette-Gu\u00e9rin (BCG)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-05-12"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.